Global Threat of GI Cancers

Gastrointestinal cancers, particularly stomach and colorectal cancer, are on the rise worldwide. Early-stage cancers often remain asymptomatic for years, leading to delayed diagnoses and poor patient outcomes. The need for AI-powered early detection and continuous monitoring systems has never been greater.

Key Risk Factors Driving Cancer Growth

• Helicobacter pylori infection increases the risk of stomach cancer by 2 to 6 times.

• Chronic gastric inflammation leads to a 6-fold increase in atrophic gastritis, progressing to 10-20 times higher cancer risk.

• Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis, significantly raises the risk of colorectal cancer (up to 7 times higher in severe cases).

• 80-85% of colorectal cancer cases originate from precancerous polyps, making early detection critical.

Gastrointestinal Cancer Statistics

United States

• Colorectal cancer (15.7%) is the second leading cause of cancer-related deaths in the U.S.

• Stomach cancer (4%) is a growing concern, though less common than colorectal cancer.

• Digestive cancers make up 19.7% of all cancer cases in the U.S., ranking third among cancer categories. (Source: 2022 American Cancer Society)

Global Trends

• Colorectal cancer (9.6%) is among the top 3 most common cancers worldwide.

• Stomach cancer (4.9%) is prevalent in high-risk regions like East Asia, Europe, and Latin America.

• Digestive cancers account for 14.5% of all cancer cases globally, making them the #1 category of cancer incidence worldwide. (Source: 2024 WHO Report)